influenzinum 200c
Generic: influenzinum (2021-2022)
Labeler: energique, inc.Drug Facts
Product Profile
Brand Name
influenzinum 200c
Generic Name
influenzinum (2021-2022)
Labeler
energique, inc.
Dosage Form
LIQUID
Routes
Active Ingredients
influenza a virus a/tasmania/503/2020 ivr-221 (h3n2) antigen (formaldehyde inactivated) 200 [hp_C]/mL, influenza a virus a/victoria/2570/2019 ivr-215 (h1n1) antigen (formaldehyde inactivated) 200 [hp_C]/mL, influenza b virus b/phuket/3073/2013 antigen (formaldehyde inactivated) 200 [hp_C]/mL, influenza b virus b/washington/02/2019 antigen (formaldehyde inactivated) 200 [hp_C]/mL
Manufacturer
Identifiers & Regulatory
Product NDC
44911-0652
Product ID
44911-0652_9577b1f9-bb12-4371-b692-759612382fbf
Product Type
HUMAN OTC DRUG
Marketing Category
UNAPPROVED HOMEOPATHIC
Marketing Start
2022-02-15
Marketing End
2027-03-30
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
449110652
Hyphenated Format
44911-0652
Supplemental Identifiers
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
influenzinum 200c (source: ndc)
Generic Name
influenzinum (2021-2022) (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 [hp_C]/mL
Packaging
- 30 mL in 1 BOTTLE, DROPPER (44911-0652-1)
Packages (1)
Ingredients (4)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "9577b1f9-bb12-4371-b692-759612382fbf", "openfda": {"upc": ["0363113600056"], "unii": ["V529EJB2CX", "WD5E5VYM2E", "B93BQX9789", "VEH9U90EHX"], "spl_set_id": ["c7954000-e6f8-4a12-8e3c-144de321ef9d"], "manufacturer_name": ["Energique, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 mL in 1 BOTTLE, DROPPER (44911-0652-1)", "package_ndc": "44911-0652-1", "marketing_end_date": "20270330", "marketing_start_date": "20220215"}], "brand_name": "Influenzinum 200C", "product_id": "44911-0652_9577b1f9-bb12-4371-b692-759612382fbf", "dosage_form": "LIQUID", "product_ndc": "44911-0652", "generic_name": "Influenzinum (2021-2022)", "labeler_name": "Energique, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Influenzinum 200C", "active_ingredients": [{"name": "INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)", "strength": "200 [hp_C]/mL"}, {"name": "INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)", "strength": "200 [hp_C]/mL"}, {"name": "INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)", "strength": "200 [hp_C]/mL"}, {"name": "INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)", "strength": "200 [hp_C]/mL"}], "marketing_category": "UNAPPROVED HOMEOPATHIC", "marketing_end_date": "20270330", "marketing_start_date": "20220215"}